weragoal.blogg.se - Download NCH Express Zip Plus 10.09

230000014509 gene expression Effects 0.000 claims description 193.

150000007523 nucleic acids Chemical group 0.000 claims description 203.206010050017 Lung cancer metastatic Diseases 0.000 claims description 448.206010055113 Breast cancer metastatic Diseases 0.000 claims description 483.

238000003745 diagnosis Methods 0.000 title abstract description 21.

200000000023 metastatic cancer Diseases 0.000 title claims abstract description 19.

239000000203 mixture Substances 0.000 title claims abstract description 50.

230000000051 modifying Effects 0.000 title claims abstract description 90.

Publication of WO2004063355A2 publication Critical patent/WO2004063355A2/en Publication of WO2004063355A3 publication Critical patent/WO2004063355A3/en Links Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US43905803P external-priority Application filed by Protein Design Labs, Inc. Priority date (The priority date is an assumption and is not a legal conclusion. ( en Inventor Natasha Aziz Albert Zlotnik Original Assignee Protein Design Labs, Inc. Google Patents Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancerĭownload PDF Info Publication number WO2004063355A2 WO2004063355A2 PCT/US2004/000885 US2004000885W WO2004063355A2 WO 2004063355 A2 WO2004063355 A2 WO 2004063355A2 US 2004000885 W US2004000885 W US 2004000885W WO 2004063355 A2 WO2004063355 A2 WO 2004063355A2 Authority WO WIPO (PCT) Prior art keywords metastatic lung cancer breast cancer metastatic breast cancer Prior art date Application number PCT/US2004/000885 Other languages French ( fr) Google Patents WO2004063355A2 - Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer WO2004063355A2 - Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer